InnovaRx Innova Health Strategies

F16.14

Hallucinogen abuse with hallucinogen-induced mood disorder

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 3 never code together
F16.1code
Excludes1
  • hallucinogen dependence (F16.2-)F16.2-
  • hallucinogen use, unspecified (F16.9-)F16.9-
F01-F99chapter
Excludes2
  • symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)R00-R99

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 8
F16.14code
Inclusion terms
  • Other hallucinogen use disorder, mild, with other hallucinogen induced bipolar or related disorder
  • Other hallucinogen use disorder, mild, with other hallucinogen induced depressive disorder
  • Phencyclidine use disorder, mild, with phencyclidine induced bipolar or related disorder
  • Phencyclidine use disorder, mild, with phencyclidine induced depressive disorder
F16code
Includes
  • ecstasy
  • PCP
  • phencyclidine
F01-F99chapter
Includes
  • disorders of psychological development
Index entries leading here 2
  • Disorder (of) — see also Disease
    • mood F39
    • phencyclidine use
      • mild F16.10
        • with
          • phencyclidine-induced
            • bipolar and related disorder F16.14
            • depressive disorder F16.14
    • hallucinogen use
      • mild F16.10
        • with
          • hallucinogen-induced
            • bipolar and related disorder F16.14
            • depressive disorder F16.14
  • Abuse
Alongside this code 6 same parent — F16.1
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC55 CMS28HCC137 ESRD21HCC55 ESRD24HCC55

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
F16.1
Block
F10-F19
Siblings
6

Present FY2024–FY2027.